Abstract 392: Impacto of Nifedipine on Polymorphonuclear Cells in Wounds

Abstract

Introduction: Skin wounds are a problem and many occur due to vascular diseases. There is a need for drugs (low cost) that can heal wounds. We aimed to evaluate if the use of nifedipine in wounds is associated with recruitment of polymorphonuclear cells higher than placebo. Hypothesis: Nifedipine stimulates the recruitment of polymorphonuclear in wounds. Methods: We performed 32 wounds in pigs and locally applied placebo or nifedipine (1%, 10% or 20%). Wounds were evaluated macro and microscopically at 6 different moments. A logistic longitudinal model of mixed effects was applied. For this purpose, the response to moderate or marked polymorphonuclear cells was considered as a dependend variable, with the comparison groups (placebo, nifedipine 1%, 10% and 20%) as the explanatory variable. Based on the placebo group, the OR was estimated with its respective confidence interval for the nifedipine groups at the different doses. Value of p <0.05 was considered significant. This study was approved by the animal research ethics committee. Results: The table below shows the proportion of polymorphonuclear cells among the comparison groups over the 6 analyzed moments. Conclusions: Wounds treated with nifedipine had higher recruitment of polymorphonuclear, regardless of the concentration used. This drug has potential for recruitment of this type of cell and may have a beneficial effect on healing.